On April 5th,2024, the European Commission (EFSA) provided its scientific opinion on EPPEN Biotech’s L-isoleucine fermented via corynebacterium glutamicum CGMCC 20437, acknowledging that

On April 20th, 2024, Sichuan Hebang Biotechnology Co., Ltd. released its Q1 2024 Report, disclosing operating revenue in Q1 2024 of 1.999 billion yuan, decreasing by 16.51% year on year,

On April 30th, 2024, Zhejiang NHU Co., Ltd. released its Q1 2024 Report, representing the operating revenue in Q1 2024 of 4499 million yuan, increasing by 24.54% from the previous year.

North China Pharmaceutical Co., Ltd. released its earnings in the first quarter 2024 on April 26th. In the first quarter, the company’s operating revenue totaled 2.558 billion yuan, down 3.86% year on

Northeast Pharmaceutical Group Co., Ltd. (Northeast Pharma) released its financial results for the first quarter of 2024 on April 26th. During the reporting period, the company generated a total opera

With the week-on-week rise of 51.8% in the previous week, inquiries and actual transaction volume on Mobaobuy.com in the 17th week of 2024 continued to increase by 20.7% and 12.0% respectively

In the feed-grade amino acids market, most amino acid varieties showed a slight dip in prices in both Europe and China. This includes L-Lysine (specifically 98.5% L-Lysine HCL), DL-Methionine, L-Valin

A group of Chinese Vitamin B1 manufacturers have halted offerings following a strong upholding of prices.